Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid Vax Study.

Enrico VirgilioCaterina TrevisanAngela AbbatecolaAlba MalaraAnnapina PalmieriGiorgio FedelePaola StefanelliPasqualina LeoneIlaria SchiavoniStefania MaggiStefano VolpatoRaffaele Antonelli IncalziGraziano Ondernull nullnull null

Published in: Diabetes care (2022)

Older residents of LTCFs with diabetes tended to have weaker antibody response to COVID-19 vaccination. Insulin treatment might buffer this effect and establish humoral immunity similar to that in individuals without diabetes.

Keyphrases

type diabetes
sars cov
glycemic control
cardiovascular disease
long term care
coronavirus disease
physical activity
immune response
community dwelling
respiratory syndrome coronavirus
electronic health record
insulin resistance
machine learning
adipose tissue
combination therapy